RAISING CAPITAL NOW
Parrot.MD
A new era of healthcare staffing that drives efficiency, lowers cost, and empowers both hospitals and clinicians
From Locum Tenens to Local Tenens:
The Future of Healthcare Staffing
You Can Help Solve the Physician Shortage
According to the American Medical Association, the U.S. faces a deficit of 124,000 physicians by 2034.*
The traditional locum tenens model, which places temporary medical staff in hospitals, is not sustainable due to high cost, inefficiency, and lack of transparency—all of which lead to misalignment with the priorities of both hospitals and healthcare providers.
Hospitals, clinicians, and the healthcare system desperately need a better solution.
*Source: American Medical Association. How these health system leaders are addressing doctor shortages, February 13, 2025.
The Solution: Parrot.MD
Parrot.MD's scalable, tech-powered solution for staffing helps hospitals fill open shifts in 3 easy steps:
A staffing solution that never sleeps, working 24 hours a day, 7 days a week to cover open shifts
Hospitals control their own shifts and pricing, so staffing shortages are addressed and costs are managed
Clinicians get 100% of the contracted hourly rate and can work as much or as little as they want, providing flexibility.
The Momentum
12
Facilities have adopted Parrot.MD and routinely use it
+40%
Increase in Parrot.MD shifts worked from 2024 to 2025
>80%
Clinicians who claim multiple shifts on Parrot.MD
*Source: Parrot.MD. Internal data, available upon request to accredited investors
The Offering
For Accredited Investors Only
Capital Sought: $1M
Minimum Investment: $10,000
Structure: Venture Debt
Equity: 3% Share Pro Rata
Debt: 12% Per Annum
Payment-in-Kind: Interest accrues quarterly and is capitalized into the principal balance
Cash Flow-Based Payments: 50% of the Company's quarterly free cash flow shall be applied toward repayment of the outstanding principal and accrued interest, beginning one year after capital is raised.
Parrot.MD conducts offerings of securities pursuant to the exemption from registration provided by Rule 506(c) of Regulation D. Certain non-executive personnel of the issuer may be licensed registered representatives of Dalmore Group, LLC. These registered representatives conduct securities business through Dalmore, a registered broker-dealer and member of FINRA/SIPC. Dalmore and the issuer are not affiliated. Participation in an offering is subject to certain criteria, including meeting financial suitability requirements. The securities offered are speculative, illiquid, and you may lose some or all of your investment. Before you invest, you should read the offering documentation for the relevant offering, which you may from the issuer or download for free by visiting EDGAR on the SEC’s website at www.sec.gov. This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities, and shall not constitute an offer, solicitation, or sale of any security, in any jurisdiction in which such offering, solicitation, or sale would be unlawful. See full disclosures in offering memo. The Offering memorandum and some advertising materials may contain forward-looking statements based on our current expectations, assumptions, and beliefs about future events and market conditions. These statements, identifiable by terms such as “anticipate,” “believe,” “intend,” “may,” “expect,” “plan,” “should,” and similar expressions, involve risks and uncertainties that could cause actual results to differ materially. Factors that may impact these outcomes include changes in market conditions, regulatory developments, operational performance, and other risks described in our filings with the U.S. Securities and Exchange Commission. Forward-looking statements are not guarantees of future performance, and the issuer undertakes no obligation to update them except as required by law.